Phase Forward Enhances InForm™ Solution for Improved Workflow and Productivity
WALTHAM, Mass.–(BUSINESS WIRE)–Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced significant enhancements to its InForm™ Integrated Trial Management (ITM) electronic data capture (EDC) solution, delivering new electronic clinical data management (eCDM) capabilities. The release of InForm ITM 4.6 focuses on new navigational features, customizable workflow filters and support for Oracle Database 10g and Cognos 8 Business Intelligence. The InForm ITM solution enhancements and features, combined with centralized design, coding and interoperability modules, deliver a flexible and robust platform for performing key elements of eCDM.
The InForm ITM platform is built on top of a tiered modular architecture that is scalable to meet a sponsor’s needs. This tiered architecture enables InForm to maintain integrity and performance as additional requirements are introduced and incremental features are added, providing a versatile and flexible solution with high practical value to clinical trial sponsors across a broad range of trial scenarios.
“The requirements and level of complexity within clinical trials continue to grow,” said Martin Young, Phase Forward vice president, corporate development. “Our customers need data capture and management tools flexible enough to adapt to these changes. We believe the InForm ITM platform is well-suited to provide this flexibility, and the enhancements in this new release underscore our commitment to providing the solutions designed to meet sponsor organizations’ need to improve productivity and increase cost savings.”
About InForm ITM
The InForm ITM 4.6 platform leverages the power of integrated modules, including the following, to accelerate study design and maximize clinical data management:
- The Central Designer™ product for study design and build
- The Central Coding™ product for automatic and manual coding of drug and adverse event terms
- The InForm Portal solution for secure site and sponsor communication
- The InForm Unplugged™ solution for remote and offline data capture and management
- The InForm CRF Submit™ product for archiving and e-submission to regulatory agencies
- The InForm Adapter product for interoperability via Web services-based interfaces
From study protocol to regulatory submission, the InForm ITM platform delivers the end-to-end eCDM capabilities sponsors and sites rely on to capture, manage and evaluate collected data, from the smallest and earliest phase trials to the largest, later phase trials. Built on standards that feature a Services Oriented Architecture (SOA), Web services-based interoperability and native support for the Oracle database, the InForm ITM platform delivers the eCDM standard that life sciences companies demand.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. The company offers proven solutions for electronic data capture (InForm™), clinical data management (Clintrial™), clinical trials signal detection (CTSD™), strategic pharmacovigilance (WebVDME™ and Signal Management), adverse event reporting (Clintrace™) and applied data standards (WebSDM™). In addition, the company provides services in the areas of application implementation, hosting and validation, data integration, business process optimization, safety data management and industry standards. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 250 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
